Calderaro Charles III bought RNA
January 6, 2025 · Form 4 insider transaction
Calderaro Charles III bought 40,000 shares of Atrium Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
40,000
Price
$0.00
Total value
N/A
InsiderCalderaro Charles III
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 6, 2025
Filing dateJanuary 8, 2025
Shares owned after40,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in four equal installments on the first four anniversaries of January 6, 2025, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.